Ley Sander

{{Use dmy dates|date=April 2022}}

Josemir W. Sander, also known as Ley Sander, is a Professor of Neurology and Clinical Epilepsy, and the head of Department of Clinical and Experimental Epilepsy, at UCL Queen Square Institute of Neurology. He is also a Professor of Neurology at West China Hospital, Sichaun University in Chengdu, China.

He is a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square London. He is the Medical Director of the Chalfont Centre for Epilepsy and of the Epilepsy Society in Buckinghamshire. Sander is the Director of Scientific Research at SEIN – Centre of expertise in epilepsy and sleep medicine in Heemstede, The Netherlands.

Sander was the Head of the World Health Organization Collaborating Centre for Research and Training in Neurosciences.

The last 10 years Sander is in the top of ExpertScape{{Cite web |title=Epilepsy: Sander, J W - Expertscape.com |url=https://expertscape.com/au/epilepsy/Sander,+J+W |access-date=2024-01-15 |website=expertscape.com}} and has a h-index of 126 on Google Scholar.{{Cite web |title=Ley Sander, MD PhD FRCP FEAN FMedSci |url=https://scholar.google.com/citations?user=QaDfoYIAAAAJ&hl=en |access-date=2024-01-15 |website=scholar.google.com}}

Fellow of the European Academy of Medical Science.

The Academy of Medical Sciences has elected Ley Sander, amongst 59 other influential biomedical and health scientists, to its respected [https://acmedsci.ac.uk/fellows/fellows-directory/ordinary-fellows/fellow/Ley-Sander-0033z000031YacFAAS Fellowship], announced on May 18 2023.{{Cite web |title=Outstanding biomedical and health researchers elected to Academy of Medical Sciences Fellowship |url=https://acmedsci.ac.uk/more/news/outstanding-biomedical-and-health-researchers-elected-to-academy-of-medical-sciences-fellowship |access-date=2024-01-15 |website=acmedsci.ac.uk}}

The new Fellows have been elected to the Academy in recognition of their exceptional contributions to the advancement of biomedical and health science, cutting edge research discoveries, and translating developments into benefits for patients and wider society.

Fellows are drawn from institutions across the UK and their breadth of expertise ranges from molecular imaging to biostatistics to public health policy. They join a prestigious Fellowship of 1,400 esteemed researchers who are central to the Academy’s work. This includes providing career support to the next generation of researchers and contributing to the Academy’s influential policy work to improve health in the UK and globally.